📰 Pharma Services News
Page 33 - Pharma Services News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharma Services. Real-time updates on events, politics, business and more.
April 7, 2022
National Bank of Canada FI acquired a new position in shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) during the 4th quarter, Holdings Channel.com reports. The firm acquired 3,700 shares of the medical research company’s stock, valued at approximately $126,000. A number of other institutional investors have also modified their holdings of NEO. Thrivent Financial […]
April 7, 2022
We have used the March return data of small-cap stocks to rank the ten worst performing small-cap stocks in March 2022.
April 5, 2022
Shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) have received an average recommendation of “Hold” from the thirteen brokerages that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the company. The average […]
April 2, 2022
NeoGenomics (NASDAQ:NEO – Get Rating) had its price objective cut by Benchmark from $26.00 to $16.00 in a research report sent to investors on Tuesday, The Fly reports. A number of other research firms have also recently issued reports on NEO. SVB Leerink cut their price objective on NeoGenomics from $45.00 to $20.00 and set […]
April 1, 2022
NeoGenomics (NASDAQ:NEO – Get Rating) had its price objective trimmed by Needham & Company LLC from $29.00 to $19.00 in a report issued on Tuesday, The Fly reports. The firm currently has a buy rating on the medical research company’s stock. Other research analysts also recently issued research reports about the company. SVB Leerink reduced […]
April 1, 2022
NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) – Research analysts at SVB Leerink cut their Q1 2022 EPS estimates for shares of NeoGenomics in a note issued to investors on Monday, March 28th. SVB Leerink analyst P. Souda now anticipates that the medical research company will earn ($0.31) per share for the quarter, down from their […]
April 1, 2022
Shares of NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) saw an uptick in trading volume on Wednesday . 86,674 shares changed hands during trading, a decline of 93% from the previous session’s volume of 1,174,509 shares.The stock last traded at $12.88 and had previously closed at $12.49. A number of research firms recently commented on NEO. […]
March 30, 2022
Stephens lowered shares of NeoGenomics (NASDAQ:NEO – Get Rating) from an overweight rating to an equal weight rating in a research note issued to investors on Tuesday, Marketbeat.com reports. Stephens currently has $16.00 target price on the medical research company’s stock, down from their prior target price of $34.00. A number of other equities research […]
March 30, 2022
NeoGenomics (NASDAQ:NEO – Get Rating) had its price objective lowered by SVB Leerink from $45.00 to $20.00 in a research report released on Tuesday, The Fly reports. The firm currently has an outperform rating on the medical research company’s stock. Several other equities research analysts have also weighed in on the stock. Raymond James cut […]
March 30, 2022
PCI Pharma Services has added innovative, state-of-the-art equipment to its San Diego, Calif., and Melbourne, Australia, sites, enhancing its global offerings.